Patents by Inventor Debottam SINHA

Debottam SINHA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Adoptive immunotherapy
    Patent number: 12779032
    Abstract: Provided herein is the use of a first population of allogeneic T-cells recognizing a first EBV epitope, and a second allogenic population recognizing a second EBV epitope in the treatment of EBV-associated disorders. Also disclosed is the use of a population of allogeneic T-cells recognizing an EBV antigen in combination with a further therapeutic agent such as an immunotherapeutic agent, a MAPK, BET or MEK pathway inhibitor for treating EBV-associated disease.
    Type: Grant
    Filed: October 23, 2020
    Date of Patent: November 3, 2026
    Assignee: The Council of the Queensland Institute of Medical Research
    Inventors: Rajiv Khanna, Debottam Sinha
  • ADOPTIVE IMMUNOTHERAPY
    Publication number: 20230210984
    Abstract: Disclosed herein is the use of a first population of allogeneic T-cells recognizing a first EBV epitope, and a second allogeneic population recognizing a second EBV epitope in the treatment of EBV-associated disorders. Also disclosed is the use of a population of allogeneic T-cells recognizing an EBV antigen in combination with a further therapeutic agent such as an immunotherapeutic agent, a MAPK, BET or MEK. pathway inhibitor for treating EBV-associated disease.
    Type: Application
    Filed: October 23, 2020
    Publication date: July 6, 2023
    Inventors: Rajiv KHANNA, Debottam SINHA